Hypertension and Dyslipidemia Clinical Trial
Official title:
A Multi-center, Prospective Observational Study to Evaluate the Effectiveness of a Combination Drug Including Fimasartan and Statins in Patients With Hypertension and Dyslipidemia
The primary objective of this study is to evaluate the effectiveness of a combination drug containing fimasartan and statins on the control of hypertension and dyslipidemia, and the secondary objective is to evaluate the drug cost reduction effect, patients' satisfaction level and safety of the combination drug administration.
This study is designed as a non-interventional, multicenter, prospective observational study for patients with hypertension and dyslipidemia. If a patient voluntarily provides written consent to provide information for this study, the enrollment number will be assigned to subjects who meet the inclusion/exclusion criteria, and follow-up will be conducted for approximately 12 weeks. Pre-specified study-related data will be collected in the case report form during the observation period. This is an observational study, and the number or interval of subjects' visits to the hospital is determined by the investigators' clinical judgment under actual medical circumstances in principle. Whether to participate in this study will not affect the patients' treatment (physician's prescription or diagnostic, therapeutic decisions). The follow-up time points specified below indicate the time points of data collection. That is, the schedule of subjects' visits is freely determined by the investigators based on the medical condition of the subjects regardless of the follow-up time points specified in this protocol, but data that are generated during the study period and are deemed necessary in relation to the study may be collected in the case report form. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05549401 -
Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348
|
Phase 1 | |
| Completed |
NCT05552495 -
Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-386 in Healthy Volunteers Under Fasting Conditions
|
Phase 1 | |
| Completed |
NCT04987970 -
A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) 80/20/10mg
|
Phase 1 | |
| Completed |
NCT04587206 -
A Clinical Trial to Evaluate the Pharmacokinetics and Tolerability of CKD-348
|
Phase 1 | |
| Completed |
NCT02933658 -
Study of Multiple Oral Dosing to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers
|
Phase 1 | |
| Completed |
NCT05335044 -
Study to Evaluate the Safety and Pharmacokinetics of CKD-331
|
Phase 1 | |
| Completed |
NCT05245084 -
A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(3) 80/20/10mg
|
Phase 1 | |
| Completed |
NCT04883658 -
A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(2)
|
Phase 1 | |
| Completed |
NCT05698043 -
A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(5) 80/20/10mg
|
Phase 1 | |
| Completed |
NCT04660370 -
A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348
|
Phase 1 | |
| Completed |
NCT04673864 -
A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386
|
Phase 1 | |
| Completed |
NCT05192356 -
A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(3)
|
Phase 1 | |
| Completed |
NCT04694989 -
A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2)
|
Phase 1 | |
| Completed |
NCT05749861 -
A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(5)
|
Phase 1 |